Document is current
Any future updates will be listed below
-
Authors
Vlasakova, Katerina http://orcid.org/0000-0002-3223-195X
Steinhilber, Andreas
Bailey, Wendy J.
Erdos, Zoltan
Haag, Hanna
Joos, Thomas
Ackermann, Bradley L.
Poetz, Oliver
Glaab, Warren E.
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (No 821283)
- License Information
-
More Information
Article History
Received: 13 October 2022
Accepted: 16 November 2022
First Online: 8 December 2022
Declarations
:
: The authors declare the following competing financial interest(s): O.P. is shareholder of SIGNATOPE GmbH. SIGNATOPE offers assay development and services using MS-based immunoassay technology.
